DK1651260T3 - Lawsonia intracellularis af europæisk oprindelse og vacciner, diagnostiske midler og fremgangsmåder til anvendelse deraf - Google Patents

Lawsonia intracellularis af europæisk oprindelse og vacciner, diagnostiske midler og fremgangsmåder til anvendelse deraf

Info

Publication number
DK1651260T3
DK1651260T3 DK04778282T DK04778282T DK1651260T3 DK 1651260 T3 DK1651260 T3 DK 1651260T3 DK 04778282 T DK04778282 T DK 04778282T DK 04778282 T DK04778282 T DK 04778282T DK 1651260 T3 DK1651260 T3 DK 1651260T3
Authority
DK
Denmark
Prior art keywords
vaccines
methods
diagnostic agents
lawsonia intracellularis
european origin
Prior art date
Application number
DK04778282T
Other languages
English (en)
Other versions
DK1651260T4 (da
Inventor
Michael B Roof
Jeremy J Kroll
Jeffrey P Knittel
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34115340&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1651260(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Application granted granted Critical
Publication of DK1651260T3 publication Critical patent/DK1651260T3/da
Publication of DK1651260T4 publication Critical patent/DK1651260T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK04778282.6T 2003-07-25 2004-07-15 Lawsonia intracellularis af europæisk oprindelse og vacciner, diagnostiske midler og fremgangsmåder til anvendelse deraf DK1651260T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49000103P 2003-07-25 2003-07-25
PCT/US2004/022704 WO2005011731A1 (en) 2003-07-25 2004-07-15 Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof

Publications (2)

Publication Number Publication Date
DK1651260T3 true DK1651260T3 (da) 2010-01-11
DK1651260T4 DK1651260T4 (da) 2018-10-08

Family

ID=34115340

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04778282.6T DK1651260T4 (da) 2003-07-25 2004-07-15 Lawsonia intracellularis af europæisk oprindelse og vacciner, diagnostiske midler og fremgangsmåder til anvendelse deraf

Country Status (23)

Country Link
US (2) US7312065B2 (da)
EP (1) EP1651260B2 (da)
JP (1) JP2006528882A (da)
KR (1) KR101131845B1 (da)
CN (2) CN1829529B (da)
AT (1) ATE442163T2 (da)
AU (1) AU2004260657B2 (da)
BR (1) BRPI0412911B1 (da)
CA (1) CA2533559C (da)
CY (1) CY1109652T1 (da)
DE (1) DE602004023094D1 (da)
DK (1) DK1651260T4 (da)
ES (1) ES2333334T5 (da)
MX (1) MXPA06000994A (da)
MY (1) MY140208A (da)
PL (1) PL1651260T5 (da)
PT (1) PT1651260E (da)
RU (1) RU2420570C2 (da)
SG (1) SG144909A1 (da)
SI (1) SI1651260T2 (da)
UA (1) UA87665C2 (da)
WO (1) WO2005011731A1 (da)
ZA (1) ZA200510081B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
AU2012207016B2 (en) * 2005-03-14 2015-01-15 Boehringer Ingelheim Animal Health USA Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
EP3868400A1 (en) 2005-12-29 2021-08-25 Boehringer Ingelheim Animal Health USA Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
DK3766518T3 (da) 2005-12-29 2026-04-13 Boehringer Ingelheim Animal Health Usa Inc Immunogen pcv2-sammensætning til mindskelse af kliniske symptomer hos grise
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
US20100136060A1 (en) * 2006-11-22 2010-06-03 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
EP2859900A1 (en) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
PT2094872T (pt) * 2006-12-15 2017-04-27 Boehringer Ingelheim Vetmedica Inc Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
TW200918666A (en) * 2007-09-11 2009-05-01 Wyeth Corp Attenuated mycoplasma gallisepticum strains
EP2200643B1 (en) 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. A live lawsonia intracellularis vaccine administered in combination with an antibiotic for use in the treatment of lawsonia intracellularis infections in pigs
CN101932336B (zh) * 2007-12-31 2014-07-09 贝林格尔.英格海姆维特梅迪卡有限公司 有外来氨基酸插入的pcv2 orf2病毒样颗粒
KR20100113582A (ko) 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
EP2254595A4 (en) * 2008-02-15 2012-12-05 Boehringer Ingelheim Vetmed METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
US8557254B2 (en) * 2008-07-22 2013-10-15 Intervet Inc. Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel Lawsonia intracellularis serotype and hybridomas for producing the said antibodies
US8142760B2 (en) * 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis
WO2011006880A1 (en) * 2009-07-14 2011-01-20 Intervet International B.V. Lawsonia intracellularis propagation
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
US8530223B2 (en) 2009-11-09 2013-09-10 Intervet International B.V. Method to grow Lawsonia intracellularis bacteria in persistently infected McCoy cells
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CN105579060B (zh) 2013-09-25 2021-03-16 硕腾服务有限责任公司 Pcv2b趋异株疫苗组合物以及使用方法
MX373884B (es) 2013-10-02 2020-03-26 Boehringer Ingelheim Animal Health Usa Inc Variante de la proteína pcv2 orf2 y partículas similares al virus compuestas por ésta.
KR102547168B1 (ko) * 2013-12-03 2023-06-22 인터벳 인터내셔널 비.브이. 로소니아 인트라셀룰라리스 및 돼지 써코바이러스 2에 대한 백신
CN103823063B (zh) * 2014-02-25 2015-09-30 上海理工大学 检测猪霍乱沙门氏菌的方法及其单抗
RU2709197C2 (ru) 2015-02-04 2019-12-17 Интервет Интернэшнл Б.В. Вакцина для применения против субклинической инфекции lawsonia у свиней
KR101893827B1 (ko) * 2016-01-04 2018-08-31 전북대학교 산학협력단 약독화된 살모넬라 변이주를 유효성분으로 포함하는 돼지 증식성 회장염 및 살모넬라증 동시 예방 또는 치료용 백신 조성물
EP3758740A1 (en) 2018-02-28 2021-01-06 Boehringer Ingelheim Vetmedica GmbH Method for reducing skatole and/or indole in animals
KR102249189B1 (ko) * 2020-01-09 2021-05-07 전북대학교 산학협력단 항원성이 증진된 항원을 발현하는 약독화된 살모넬라 변이주를 유효성분으로 포함하는 돼지 증식성 회장염 및 살모넬라증 동시 예방 또는 치료용 백신 조성물
EP4185321A2 (en) * 2020-07-24 2023-05-31 Boehringer Ingelheim Animal Health USA Inc. Combination porcine vaccine
CN111961627A (zh) * 2020-08-27 2020-11-20 南京农业大学 一种胞内劳森菌的分离与培养方法
US12409212B2 (en) 2021-11-01 2025-09-09 Boehringer Ingelheim Vetmedica Gmbh Immunogenic gel compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714375A (en) * 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents

Also Published As

Publication number Publication date
DK1651260T4 (da) 2018-10-08
US20050031647A1 (en) 2005-02-10
ATE442163T2 (de) 2009-09-15
RU2006105715A (ru) 2007-09-10
EP1651260B1 (en) 2009-09-09
AU2004260657A1 (en) 2005-02-10
US20080112980A1 (en) 2008-05-15
CA2533559C (en) 2013-07-02
US7758870B2 (en) 2010-07-20
UA87665C2 (ru) 2009-08-10
KR20060054352A (ko) 2006-05-22
AU2004260657B2 (en) 2012-06-07
CY1109652T1 (el) 2014-08-13
CN1829529A (zh) 2006-09-06
ES2333334T5 (es) 2018-08-06
PT1651260E (pt) 2009-09-24
WO2005011731A1 (en) 2005-02-10
DE602004023094D1 (de) 2009-10-22
MY140208A (en) 2009-11-30
RU2420570C2 (ru) 2011-06-10
PL1651260T5 (pl) 2018-11-30
SI1651260T2 (sl) 2018-09-28
CA2533559A1 (en) 2005-02-10
ZA200510081B (en) 2006-08-30
EP1651260B2 (en) 2018-06-27
EP1651260A1 (en) 2006-05-03
SI1651260T1 (sl) 2010-01-29
BRPI0412911B1 (pt) 2020-01-21
US7312065B2 (en) 2007-12-25
CN1829529B (zh) 2011-05-04
BRPI0412911A (pt) 2006-09-26
CN101423811A (zh) 2009-05-06
SG144909A1 (en) 2008-08-28
JP2006528882A (ja) 2006-12-28
PL1651260T3 (pl) 2010-02-26
MXPA06000994A (es) 2006-05-15
ES2333334T3 (es) 2010-02-19
KR101131845B1 (ko) 2012-03-30

Similar Documents

Publication Publication Date Title
DK1651260T3 (da) Lawsonia intracellularis af europæisk oprindelse og vacciner, diagnostiske midler og fremgangsmåder til anvendelse deraf
DE602004022347D1 (de) Testeinrichtung und Testverfahren
PL1971366T3 (pl) Ludzkie przeciwciała skierowane przeciw IL-23, kompozycje, sposoby i zastosowanie
DK1638999T3 (da) Sammensætninger og fremgangsmåder til øgning af knoglemineralisering
NO20055018D0 (no) Anti-amyolide antistoffer, sammensetninger, fremgangsmater og anvendelser
DE602004017351D1 (de) Fft-architektur und -verfahren
DE602004007498D1 (de) Testemulationseinrichtung
IS7726A (is) Pyrazólólpyridín og aðferðir til þess að búa þau til og nota
NO20055686L (no) Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
DE602005015463D1 (de) Testvorrichtung & -verfahren
DK1817055T3 (da) Ovr110-antistofsammensætninger og fremgangsmåder til anvendelse heraf
NL1033063A1 (nl) Tomografische beeldvormingsapparatuur en tomografische beeldvormingswerkwijze.
DE602004029376D1 (de) Fettzusammensetzung für backware, sowie backware
DE602004016877D1 (de) Untersuchungsstuhl
DK1761785T3 (da) Fremgangsmåde til diagnosticering af Lawsonia intracellularis
DK1819489T3 (da) Indretning og fremgangsmåde til portionering
DK1662867T3 (da) Insekticid-forbindelser og fremgangsmåder til valg deraf
DE602004016159D1 (de) Testeinrichtung
DE602005014560D1 (de) Ileitis-diagnosetest
SE0303177L (sv) Undersökningsmetod och -anordning
DK1768691T3 (da) Aequorinholdige præparater og fremgangsmåder til anvendelse af samme
NO20054049D0 (no) Fremgangsmate for diagnose og behandling.
DE602004014025D1 (de) Betätigungsvorrichtung und -verfahren
DE60309128D1 (de) LSI-Testanordnung
SE0300181L (sv) Simuleringsförfarande